MSD launches Januvia 25mg, completing portfolio for nephropathy patients
Because launching Januvia 25mg, MSD has become available to make prescriptions for nephropathy patients on every stage.
At the press conference on the 29th, MSD Korea announced the launch of the diabetes type 2 treatment ‘Januvia(generic name: sitagliptin) 25mg’ on April.
Although Januvia 100mg...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
